{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T15:23:40Z","timestamp":1717773820208},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00399-020-00697-5","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:03:31Z","timestamp":1594631011000},"page":"394-400","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Welche Bedeutung hat die Genetik in der Rhythmologie?"],"prefix":"10.1007","volume":"31","author":[{"given":"Marina","family":"Rieder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babken","family":"Asatryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja E.","family":"Odening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"697_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00109-018-1685-y","volume":"96","author":"B Asatryan","year":"2018","unstructured":"Asatryan\u00a0B, Medeiros-Domingo\u00a0A (2018) Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies. J\u00a0Mol Med 96:993\u20131024","journal-title":"J Mol Med"},{"key":"697_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CRD.0000000000000203","volume":"27","author":"B Asatryan","year":"2019","unstructured":"Asatryan\u00a0B, Medeiros-Domingo\u00a0A (2019) Emerging implications of genetic testing in inherited primary arrhythmia syndromes. Cardiol Rev 27:23\u201333","journal-title":"Cardiol Rev"},{"key":"697_CR3","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","volume":"10","author":"SG Priori","year":"2013","unstructured":"Priori\u00a0SG, Wilde\u00a0AA, Horie\u00a0M et\u00a0al (2013) HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10:1932\u20131963","journal-title":"Heart Rhythm"},{"key":"697_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1056\/NEJM199810013391404","volume":"339","author":"W Zareba","year":"1998","unstructured":"Zareba\u00a0W, Moss\u00a0AJ, Schwartz\u00a0PJ et al (1998) Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N\u00a0Engl J Med 339:960\u2013965","journal-title":"N Engl J Med"},{"key":"697_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","volume":"103","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz\u00a0PJ, Priori\u00a0SG, Spazzolini\u00a0C et al (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89\u201395","journal-title":"Circulation"},{"key":"697_CR6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/hc0702.105124","volume":"105","author":"AJ Moss","year":"2002","unstructured":"Moss\u00a0AJ, Zareba\u00a0W, Kaufman\u00a0ES et al (2002) Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794\u2013799","journal-title":"Circulation"},{"key":"697_CR7","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","volume":"14","author":"MJ Ackerman","year":"2017","unstructured":"Ackerman\u00a0MJ, Priori\u00a0SG, Dubin\u00a0AM et al (2017) Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart Rhythm 14:e41\u2013e44","journal-title":"Heart Rhythm"},{"key":"697_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","volume":"67","author":"A Mazzanti","year":"2016","unstructured":"Mazzanti\u00a0A, Maragna\u00a0R, Faragli\u00a0A et al (2016) Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. J\u00a0Am Coll Cardiol 67:1053\u20131058","journal-title":"J Am Coll Cardiol"},{"key":"697_CR9","doi-asserted-by":"publisher","first-page":"H2264","DOI":"10.1152\/ajpheart.00680.2008","volume":"295","author":"KE Odening","year":"2008","unstructured":"Odening\u00a0KE, Hyder\u00a0O, Chaves\u00a0L et al (2008) Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization. Am J Physiol Heart Circ Physiol 295:H2264\u2013H2272","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"697_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/europace\/eus042","volume":"14","author":"PG Postema","year":"2012","unstructured":"Postema\u00a0PG (2012) About Brugada syndrome and its prevalence. Europace 14:925\u2013928","journal-title":"Europace"},{"key":"697_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0735-1097(98)00528-2","volume":"33","author":"I Gussak","year":"1999","unstructured":"Gussak\u00a0I, Antzelevitch\u00a0C, Bjerregaard\u00a0P et\u00a0al (1999) The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J\u00a0Am Coll Cardiol 33:5\u201315","journal-title":"J Am Coll Cardiol"},{"key":"697_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","volume":"72","author":"J Brugada","year":"2018","unstructured":"Brugada\u00a0J, Campuzano\u00a0O, Arbelo\u00a0E et al (2018) Present status of Brugada syndrome: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 72:1046\u20131059","journal-title":"J Am Coll Cardiol"},{"key":"697_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ng.2712","volume":"45","author":"CR Bezzina","year":"2013","unstructured":"Bezzina\u00a0CR, Barc\u00a0J, Mizusawa\u00a0Y et al (2013) Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a\u00a0rare disease with high risk of sudden cardiac death. Nat Genet 45:1044\u20131049","journal-title":"Nat Genet"},{"key":"697_CR14","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstrom-Lundqvist\u00a0C, Mazzanti\u00a0A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart\u00a0J 36:2793\u20132867","journal-title":"Eur Heart J"},{"key":"697_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","volume":"103","author":"SG Priori","year":"2001","unstructured":"Priori\u00a0SG, Napolitano\u00a0C, Tiso\u00a0N et\u00a0al (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196\u2013200","journal-title":"Circulation"},{"key":"697_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/europace\/eur245","volume":"13","author":"MJ Ackerman","year":"2011","unstructured":"Ackerman\u00a0MJ, Priori\u00a0SG, Willems\u00a0S et\u00a0al (2011) HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a\u00a0partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13:1077\u20131109","journal-title":"Europace"},{"key":"697_CR17","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.amjcard.2019.02.061","volume":"123","author":"B Asatryan","year":"2019","unstructured":"Asatryan\u00a0B, Schaller\u00a0A, Seiler\u00a0J et\u00a0al (2019) Usefulness of genetic testing in sudden cardiac arrest survivors with or without previous clinical evidence of heart disease. Am J Cardiol 123:2031\u20132038","journal-title":"Am J Cardiol"},{"key":"697_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003817","author":"M Visser","year":"2016","unstructured":"Visser\u00a0M, van der Heijden\u00a0JF, Doevendans\u00a0PA et al (2016) Idiopathic ventricular fibrillation: the struggle for definition, diagnosis, and follow-up. Circ Arrhythm Electrophysiol. https:\/\/doi.org\/10.1161\/CIRCEP.115.003817","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"697_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott\u00a0P, Andersson\u00a0B, Arbustini\u00a0E et\u00a0al (2008) Classification of the cardiomyopathies: a\u00a0position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart\u00a0J 29:270\u2013276","journal-title":"Eur Heart J"},{"key":"697_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","volume":"60","author":"BJ Maron","year":"2012","unstructured":"Maron\u00a0BJ, Maron\u00a0MS, Semsarian\u00a0C (2012) Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J\u00a0Am Coll Cardiol 60:705\u2013715","journal-title":"J Am Coll Cardiol"},{"key":"697_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.hrthm.2011.08.009","volume":"9","author":"BJ Maron","year":"2012","unstructured":"Maron\u00a0BJ, Maron\u00a0MS, Semsarian\u00a0C (2012) Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a\u00a0potential link to sudden death in the absence of conventional risk factors. Heart Rhythm 9:57\u201363","journal-title":"Heart Rhythm"},{"key":"697_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11886-018-1030-7","volume":"20","author":"A Paldino","year":"2018","unstructured":"Paldino\u00a0A, De Angelis\u00a0G, Merlo\u00a0M et\u00a0al (2018) Genetics of dilated cardiomyopathy: clinical implications. Curr Cardiol Rep 20:83","journal-title":"Curr Cardiol Rep"},{"key":"697_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","volume":"3","author":"AW El-Hattab","year":"2016","unstructured":"El-Hattab\u00a0AW, Scaglia\u00a0F (2016) Mitochondrial cardiomyopathies. Front Cardiovasc Med 3:25","journal-title":"Front Cardiovasc Med"},{"key":"697_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IA van Rijsingen","year":"2012","unstructured":"van Rijsingen\u00a0IA, Arbustini\u00a0E, Elliott\u00a0PM et\u00a0al (2012) Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a\u00a0European cohort study. J\u00a0Am Coll Cardiol 59:493\u2013500","journal-title":"J Am Coll Cardiol"},{"key":"697_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","volume":"106","author":"E Kayvanpour","year":"2017","unstructured":"Kayvanpour\u00a0E, Sedaghat-Hamedani\u00a0F, Amr\u00a0A et al (2017) Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol 106:127\u2013139","journal-title":"Clin Res Cardiol"},{"key":"697_CR26","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","volume":"74","author":"M Gigli","year":"2019","unstructured":"Gigli\u00a0M, Merlo\u00a0M, Graw\u00a0SL et\u00a0al (2019) Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J\u00a0Am Coll Cardiol 74:1480\u20131490","journal-title":"J Am Coll Cardiol"},{"key":"697_CR27","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","volume":"121","author":"FI Marcus","year":"2010","unstructured":"Marcus\u00a0FI, McKenna\u00a0WJ, Sherrill\u00a0D et\u00a0al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria. Circulation 121:1533\u20131541","journal-title":"Circulation"},{"key":"697_CR28","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","volume":"61","author":"FI Marcus","year":"2013","unstructured":"Marcus\u00a0FI, Edson\u00a0S, Towbin\u00a0JA (2013) Genetics of arrhythmogenic right ventricular cardiomyopathy: a\u00a0practical guide for physicians. J\u00a0Am Coll Cardiol 61:1945\u20131948","journal-title":"J Am Coll Cardiol"},{"key":"697_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","volume":"36","author":"A Bhonsale","year":"2015","unstructured":"Bhonsale\u00a0A, Groeneweg\u00a0JA, James\u00a0CA et al (2015) Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart\u00a0J 36:847\u2013855","journal-title":"Eur Heart J"},{"key":"697_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr040","volume":"32","author":"B Pinamonti","year":"2011","unstructured":"Pinamonti\u00a0B, Dragos\u00a0AM, Pyxaras\u00a0SA et al (2011) Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a\u00a010-year registry. Eur Heart\u00a0J 32:1105\u20131113","journal-title":"Eur Heart J"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-020-00697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-020-00697-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-020-00697-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:23:10Z","timestamp":1626135790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-020-00697-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1007\/s00399-020-00697-5","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Rieder, A.\u00a0Castiglione, B.\u00a0Asatryan und K.E.\u00a0Odening geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}